Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma
Year: 2025
Type: article
Topic: Cancer Risks and Factors
Authors and affiliations:
raw_author_name: S I Neppelenbroek
raw_affiliation_strings: Netherlands Cancer Institute, Department of Epidemiology, Amsterdam, Netherlands
raw_author_name: Y M Geurts
raw_affiliation_strings: Netherlands Cancer Institute, Department of Epidemiology, Amsterdam, Netherlands
raw_author_name: B M Aleman
raw_affiliation_strings: Netherlands Cancer Institute, Department of Radiation Oncology, Amsterdam, Netherlands
raw_author_name: P J Lugtenburg
raw_affiliation_strings: Erasmus MC Cancer Center, Department of Hematoloy, Rotterdam, Netherlands
raw_author_name: S E Rademakers
raw_affiliation_strings: Leiden University Medical Center, Department of Radiation Oncology, Leiden, Netherlands
raw_author_name: R J de Weijer
raw_affiliation_strings: University Medical Center, Department of Hematology, Utrecht, Netherlands
raw_author_name: M G Schippers
raw_affiliation_strings: Instituut Verbeeten, Department of Radiation Oncology, Tilburg, Netherlands
raw_author_name: B D Ta
raw_affiliation_strings: Maastricht University Medical Centre+, Department of Radiation Oncology (Maastro) GROW School for Oncology, Maastricht, Netherlands
raw_author_name: W J Plattel
raw_affiliation_strings: University Medical Center Groningen, Department of Hematology, Groningen, Netherlands
raw_author_name: J M Zijlstra
raw_affiliation_strings: Amsterdam University Medical Centers, Location Vrije Universiteit, Cancer Center Amsterdam, Department of Hematology, Amsterdam, Netherlands
raw_author_name: R W van der Maazen
raw_affiliation_strings: Radboud University Medical Center, Department of Radiation Oncology, Nijmegen, Netherlands
raw_author_name: M R Nijziel
raw_affiliation_strings: Catharina hospital, Department of Hemato-Oncology, Catharina Cancer Institute, Eindhoven, Netherlands
raw_author_name: F Ong
raw_affiliation_strings: Medisch Spectrum Twente, Department of Radiotherapy, Enschede, Netherlands
raw_author_name: E C Schimmel
raw_affiliation_strings: Radiotherapiegroep, Department of Radiotherapy, Arnhem, Netherlands
raw_author_name: E F Posthuma
raw_affiliation_strings: Reinier de Graaf Hospital, Department of Internal Medicine, Delft, Netherlands
raw_author_name: M J Kersten
raw_affiliation_strings: Amsterdam University Medical Centers, Location University of Amsterdam, Cancer Center Amsterdam, Department of Hematology, Amsterdam, Netherlands
raw_author_name: L H Böhmer
raw_affiliation_strings: Haga Teaching Hospital, Department of Hematology, Den Haag, Netherlands
raw_author_name: K Muller
raw_affiliation_strings: Radiotherapiegroep, Department of Radiotherapy, Deventer, Netherlands
raw_author_name: H R Koene
raw_affiliation_strings: St Antonius Hospital, Department of Hematology, Nieuwegein, Netherlands
raw_author_name: L te Boome
raw_affiliation_strings: Haaglanden Medical Center, Department of Hematology, Den Haag, Netherlands
raw_author_name: Y Bilgin
raw_affiliation_strings: Admiraal De Ruyter Hospital, Department of Internal Medicine, Goes, Netherlands
raw_author_name: E de Jongh
raw_affiliation_strings: Albert Schweitzer Hospital, Department of Internal Medicine, Dordrecht, Netherlands
raw_author_name: C P Janus
raw_affiliation_strings: Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Radiotherapy, Rotterdam, Netherlands
raw_author_name: F E van Leeuwen
raw_affiliation_strings: Netherlands Cancer Institute, Department of Epidemiology, Amsterdam, Netherlands
raw_author_name: M Schaapveld
raw_affiliation_strings: Netherlands Cancer Institute, Department of Epidemiology, Amsterdam, Netherlands